HSPB1 and amyotrophic lateral sclerosis: Two other studies evaluated overexpression of HspB1 in a transgenic SOD-1G93A model of ALS; one showed no effect on disease progression (Krishnan et al., 2008), while the other showed a modest protection at early stages of disease, which were not sustained and resulted in no improvement at later stages (Sharp et al., 2008).